substance p has been researched along with Uterine Cervical Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Darban, RA; Ebrahimi, S; Hashemy, SI; Mozafari, M | 1 |
| Huang, L; Liu, H; Ma, J; Wang, Y; Yuan, S; Zhang, F | 1 |
| Liang, R; Ma, Y; Ni, J; Song, J; Wang, R; Wei, X; Zhang, L; Zhang, W; Zhang, Y | 1 |
3 other study(ies) available for substance p and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
Topics: Apoptosis; Aprepitant; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Signal Transduction; Substance P; Uterine Cervical Neoplasms | 2022 |
Substance P is overexpressed in cervical squamous cell carcinoma and promoted proliferation and invasion of cervical cancer cells in vitro.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Female; Humans; MAP Kinase Signaling System; Middle Aged; Neoplasm Invasiveness; Substance P; Uterine Cervical Neoplasms | 2023 |
Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery.
Topics: Acylation; Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chlorocebus aethiops; COS Cells; DNA Replication; Female; Genetic Therapy; Glioblastoma; Humans; Plasmids; Protein Sorting Signals; Protein Transport; Recombinant Proteins; Substance P; Transfection; Uterine Cervical Neoplasms | 2014 |